Search Within

Molecular Imaging and Therapy Service

Formats
  1. Journal Article (1834)
  2. Meeting Abstract (941)
  3. Book Section (179)
  4. Review (161)
  5. Editorial (45)
  6. Conference Paper (40)
  7. Guidelines (32)
  8. Miscellaneous (19)
  9. Correspondence (12)
  10. Research Letter (11)
  11. Book Whole (7)
Groups
  1. Radiology, Department of (3103)
  2. GSK Faculty (1491)
  3. Sloan Kettering Institute Faculty (1250)
  4. Molecular Pharmacology and Chemistry Program Faculty (1235)
  5. Department of Medicine (1003)
  6. Sloan Kettering Institute Postdocs (885)

More Groups

People
  1. Steven Larson (962)
  2. Heiko Schoder (555)
  3. Neeta Pandit-Taskar (348)
  4. John Humm (284)
  5. Hebert Vargas Alvarez (267)
  6. Lisa Bodei (211)

More People

Years
  1. 2025 (75)
  2. 2024 (134)
  3. 2023 (176)
  4. 2022 (176)
  5. 2021 (200)
  6. 2020 (195)

More Years

Publications
  1. Journal of Nuclear Medicine (577)
  2. Journal of Clinical Oncology (251)
  3. European Journal of Nuclear Medicine and Molecular Imaging (130)
  4. Blood (102)
  5. International Journal of Radiation Oncology, Biology, Physics (73)
  6. Clinical Nuclear Medicine (72)

More Publications

Publishers
  1. Society of Nuclear Medicine (577)
  2. Springer (434)
  3. Elsevier Inc. (286)
  4. American Society of Clinical Oncology (263)
  5. Lippincott Williams & Wilkins (155)
  6. American Association for Cancer Research (151)

More Publishers

Results (3281)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Computational nuclear oncology toward precision radiopharmaceutical therapies: Ethical, regulatory, and socioeconomic dimensions of theranostic digital twins
    Journal Article

    Strigari, L.; Schwarz, J.; Bradshaw, T.; Brosch-Lenz, J.; Currie, G.; El-Fakhri, G.; Jha, A. K.; Mežinska, S.; Pandit-Taskar, N.; Roncali, E.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A novel predictive model using changes in clinical and serum biomarkers and automated quantitative imaging for mCRPC patients treated with AR-directed therapy
    Meeting Abstract

    Morris, M. J.; Flynn, J.; Zhao, B.; Anand, A.; Sjöstrand, K.; Larson, S. M.; Scher, H. I.; Regazzi, A. M.; Borzillo, G. V.; Park, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Updated long-term follow-up from a phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Jayalath, V.; Teo, M. Y.; Assel, M.; Rodriguez, D.; Meyerson, A.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Performance of breast MRI for high-risk screening during lactation
    Journal Article

    Nissan, N.; Gluskin, J.; Ochoa-Albiztegui, R. E.; Fruchtman-Brot, H.; Sung, J. S.; Jochelson, M. S.
    European Radiology (2025)

    Fulltext@MSK | Save
  • Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma
    Journal Article

    Corona, M.; Ip, A.; Brown, S.; Luna, A.; Khatib, H.; Flynn, J. R.; Devlin, S. M.; Landego, I.; Cassanello, G.; Rejeski, K.; more...
    Bone Marrow Transplantation (2025)

    Fulltext@MSK | Save
  • An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
    Journal Article

    Raj, S. S.; Fei, T.; Fried, S.; Ip, A.; Fein, J. A.; Leslie, L. A.; Alarcon Tomas, A.; Leithner, D.; Peled, J. U.; Corona, M.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Methylation analysis reveals epigenetic congruence between bone sarcomas with H3-3A mutations and malignant giant cell tumors of bone
    Journal Article

    Saoud, C.; Benhamida, J.; Borsu, L.; Villafania, L.; Linos, K.; Brannon, A. R.; Sinchun, H.; Morris, C.; Vaynrub, M.; Bartelstein, M.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Computational nuclear oncology toward precision radiopharmaceutical therapies: Current tools, techniques, and uncharted territories
    Review

    Yusufaly, T.; Roncali, E.; Brosch-Lenz, J.; Uribe, C.; Jha, A. K.; Currie, G.; Dutta, J.; El-Fakhri, G.; McMeekin, H.; Pandit-Taskar, N.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • IL13Rα2-targeting antibodies for immuno-PET in solid malignancies
    Journal Article

    Gajecki, L.; Lebedeva, I. V.; Liao, Y. R.; Ambriz, D.; Carter, L. M.; Kumpf, M.; Lovibond, S.; Hachey, J. S.; Graham, M. S.; Postow, M.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save